Combining these results, our studies suggest patients with high HIC1 expression had a better prognosis in ACC, UVM, KIRP, MESO, and TGCT, while had a worse prognosis in UCEC, BLCA, CHOL, and PCPG. The gene discussed is HIC1; the disease is adrenal cortex carcinoma.